The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

Biocon, Cipla, Dr Reddy’s, Other Pharma Stocks In Red Amid Trump Tariff Uncertainty; What Should Investors Do?

Mukesh Ambani's Reliance Industries (RIL) offloaded 85 lakh shares of Asian Paints, India’s largest paint manufacturer, ...

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

Indian pharmaceutical companies are preparing to flood the market with generic versions of Novo Nordisk’s semaglutide—sold ...

Domestic equity benchmarks slipped into the red on Tuesday, dragged down by rising tensions between Israel and Iran. Investor ...

Indian equity indices closed lower on Tuesday, with Sensex down 0.26% and Nifty down 0.37%. Tech Mahindra and Infosys gained, while Adani Enterprises and Sun Pharma declined.

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...